Physician profile
James Lin
NPI 1851406540
$343.56
in general payments reported to CMS, 2019-2025
6 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103 · 2021: $22.97 · 2022: $58.35 · 2024: $38.41 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $159.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $121.29 | 2025 | |
| Mentor Worldwide LLC | $76.86 | 2019-2021 | |
| Stryker Corporation | $48.65 | 2019 | |
| Evolution Surgical, INC | $38.41 | 2024 | |
| Smith+Nephew, INC. | $38.12 | 2022 | |
| Endo Pharmaceuticals INC. | $20.23 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.